English

Aethlon Medical, Inc.

EDGAR

AEMD Quarterly report (10-Q) · filed 2026-08-13

147 filing records in this dataset, filed from 1997-09-23 to 2026-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

574 thousand USD

2023 Q4 · USD

Exact inputs and evidence

Revenue: 574245 USD Source
Revenue: 0 USD Source

Operating margin

-431.51%

2023 Q4 · %

Exact inputs and evidence

Operating Income: -11898638 USD Source
Operating Income: -9420730 USD Source
Revenue: 574245 USD Source
Revenue: 0 USD Source

Operating cash flow

-2.95 million USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -10505128 USD Source
Operating Cash Flow: -7558412 USD Source

Free cash flow

-2.96 million USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -10505128 USD Source
Operating Cash Flow: -7558412 USD Source
Capital Expenditure: 943109 USD Source
Capital Expenditure: 931820 USD Source

Cash and cash equivalents: 4.93 million USD 2026-06-30 Source
Exact value

4933579 USD
Long-term debt including current maturities: Not available
Shares outstanding: 477 thousand shares 2026-06-30 Source
Exact value

477402 shares

Reported share-count change

-81.63% · -2.12 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

2598711 shares · 2025-06-30· Source
477402 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

574 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Revenue: 0 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 0 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 0 USD · 2022-10-01 – 2022-12-31 Source
Revenue: 574245 USD · 2022-04-01 – 2023-03-31 Source
Revenue: 0 USD · 2022-04-01 – 2022-12-31 Source

Net income

-6.94 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -1487100 USD · 2025-07-01 – 2025-09-30 Source
Net income: -2018245 USD · 2025-10-01 – 2025-12-31 Source
Net income: -7151469 USD · 2025-04-01 – 2026-03-31 Source
Net income: -5267203 USD · 2025-04-01 – 2025-12-31 Source
Net income: -1547912 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-7.18 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3373654 USD · 2025-04-01 – 2025-09-30 Source
Operating cash flow: -1714937 USD · 2025-04-01 – 2025-06-30 Source
Operating cash flow: -5248011 USD · 2025-04-01 – 2025-12-31 Source
Operating cash flow: -3373654 USD · 2025-04-01 – 2025-09-30 Source
Operating cash flow: -6998392 USD · 2025-04-01 – 2026-03-31 Source
Operating cash flow: -5248011 USD · 2025-04-01 – 2025-12-31 Source
Operating cash flow: -1896539 USD · 2026-04-01 – 2026-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2026-03-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2024-03-31
Operating income: 11 of 11 periods available· newest 2026-03-31
Net income: 11 of 11 periods available· newest 2026-03-31
Operating cash flow: 11 of 11 periods available· newest 2026-03-31
Capital expenditure: 11 of 11 periods available· newest 2026-03-31
Total assets: 11 of 11 periods available· newest 2026-03-31
Total liabilities: 11 of 11 periods available· newest 2026-03-31
Current assets: 11 of 11 periods available· newest 2026-03-31
Current liabilities: 11 of 11 periods available· newest 2026-03-31
Cash and cash equivalents: 7 of 11 periods available· newest 2026-03-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2026-03-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 6.24 million

Prior period

−USD 13.39 million

2024-04-01 – 2025-03-31
Current period

−USD 7.15 million

2025-04-01 – 2026-03-31

Exact inputs and evidence

-7151469 − -13388089 = 6236620 USD

-13388089 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
-7151469 USD · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Aethlon Medical, Inc. · 2026-03-31 Aethlon Medical, Inc. (edgar:882291) Year-over-year change in Net income: 6236620 USD Concept: fundies:NetIncome Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7151469 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1025008 Filing: 000168316826004710 Input fundies:NetIncome: -13388089 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1025376 Filing: 000168316826004710
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 647,140

Prior period

−USD 7.65 million

2024-04-01 – 2025-03-31
Current period

−USD 7 million

2025-04-01 – 2026-03-31

Exact inputs and evidence

-6998392 − -7645532 = 647140 USD

-7645532 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
-6998392 USD · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Aethlon Medical, Inc. · 2026-03-31 Aethlon Medical, Inc. (edgar:882291) Year-over-year change in Operating cash flow: 647140 USD Concept: fundies:OperatingCashFlow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -6998392 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1033971 Filing: 000168316826004710 Input fundies:OperatingCashFlow: -7645532 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1034434 Filing: 000168316826004710
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+USD 3,704

Prior period

USD 0

2024-04-01 – 2025-03-31
Current period

USD 3,704

2025-04-01 – 2026-03-31

Exact inputs and evidence

3704 − -0 = 3704 USD

-0 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
3704 USD · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Aethlon Medical, Inc. · 2026-03-31 Aethlon Medical, Inc. (edgar:882291) Year-over-year change in Capital expenditure: 3704 USD Concept: fundies:CapitalExpenditure Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3704 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1036082 Filing: 000168316826004710 Input fundies:CapitalExpenditure: -0 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1036531 Filing: 000168316826004710
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2023-04-01 – 2024-03-31

Revenue USD 0
Operating costs Derived USD 12.64 million
Operating income −USD 12.64 million
Tax, interest and other Derived −USD 428,394
Net income −USD 12.21 million

Cash

Operating cash flow −USD 10.13 million
Capital expenditure USD 250,867
Free cash flow Derived −USD 10.38 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 1,655% of revenue.
2018 Operating loss: operating costs were 3,329% of revenue.
2019 Operating loss: operating costs were 2,713% of revenue.
2020 Operating loss: operating costs were 1,012% of revenue.
2021 Operating loss: operating costs were 1,297% of revenue.
2022 Operating loss: operating costs were 3,643% of revenue.
2023 Operating loss: operating costs were 2,172% of revenue.
2024 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2016-04-01 – 2017-03-31	392073	6490430 Derived	-6098357	1177756 Derived	-7276113	-3522333 Derived	Source 2016-04-01 – 2017-03-31: 392073 USD Inspect Revenue Open source 2016-04-01 – 2017-03-31: -6098357 USD Inspect Operating Income Open source 2016-04-01 – 2017-03-31: -7276113 USD Inspect Net Income Open source 2016-04-01 – 2017-03-31: -3505900 USD Inspect Operating Cash Flow Open source 2016-04-01 – 2017-03-31: 16433 USD Inspect Capital Expenditure Open source
2018 2017-04-01 – 2018-03-31	149625	4980741 Derived	-4831116	848442 Derived	-5679558	-3935503 Derived	Source 2017-04-01 – 2018-03-31: 149625 USD Inspect Revenue Open source 2017-04-01 – 2018-03-31: -4831116 USD Inspect Operating Income Open source 2017-04-01 – 2018-03-31: -5679558 USD Inspect Net Income Open source 2017-04-01 – 2018-03-31: -3910680 USD Inspect Operating Cash Flow Open source 2017-04-01 – 2018-03-31: 24823 USD Inspect Capital Expenditure Open source
2019 2018-04-01 – 2019-03-31	229625	6228642 Derived	-5999017	195702 Derived	-6194719	-4293433 Derived	Source 2018-04-01 – 2019-03-31: 229625 USD Inspect Revenue Open source 2018-04-01 – 2019-03-31: -5999017 USD Inspect Operating Income Open source 2018-04-01 – 2019-03-31: -6194719 USD Inspect Net Income Open source 2018-04-01 – 2019-03-31: -4293433 USD Inspect Operating Cash Flow Open source 2018-04-01 – 2019-03-31: 0 USD Inspect Capital Expenditure Open source
2020 2019-04-01 – 2020-03-31	650187	6580175 Derived	-5929988	443960 Derived	-6373948	-5349273 Derived	Source 2019-04-01 – 2020-03-31: 650187 USD Inspect Revenue Open source 2019-04-01 – 2020-03-31: -5929988 USD Inspect Operating Income Open source 2019-04-01 – 2020-03-31: -6373948 USD Inspect Net Income Open source 2019-04-01 – 2020-03-31: -5197608 USD Inspect Operating Cash Flow Open source 2019-04-01 – 2020-03-31: 151665 USD Inspect Capital Expenditure Open source
2021 2020-04-01 – 2021-03-31	659104	8550603 Derived	-7891499	-4790 Derived	-7886709	-6824821 Derived	Source 2020-04-01 – 2021-03-31: 659104 USD Inspect Revenue Open source 2020-04-01 – 2021-03-31: -7891499 USD Inspect Operating Income Open source 2020-04-01 – 2021-03-31: -7886709 USD Inspect Net Income Open source 2020-04-01 – 2021-03-31: -6764940 USD Inspect Operating Cash Flow Open source 2020-04-01 – 2021-03-31: 59881 USD Inspect Capital Expenditure Open source
2022 2021-04-01 – 2022-03-31	294165	10715050 Derived	-10420885	-4794 Derived	-10416091	-10116350 Derived	Source 2021-04-01 – 2022-03-31: 294165 USD Inspect Revenue Open source 2021-04-01 – 2022-03-31: -10420885 USD Inspect Operating Income Open source 2021-04-01 – 2022-03-31: -10416091 USD Inspect Net Income Open source 2021-04-01 – 2022-03-31: -9767157 USD Inspect Operating Cash Flow Open source 2021-04-01 – 2022-03-31: 349193 USD Inspect Capital Expenditure Open source
2023 2022-04-01 – 2023-03-31	574245	12472883 Derived	-11898638	131148 Derived	-12029786	-11448237 Derived	Source 2022-04-01 – 2023-03-31: 574245 USD Inspect Revenue Open source 2022-04-01 – 2023-03-31: -11898638 USD Inspect Operating Income Open source 2022-04-01 – 2023-03-31: -12029786 USD Inspect Net Income Open source 2022-04-01 – 2023-03-31: -10505128 USD Inspect Operating Cash Flow Open source 2022-04-01 – 2023-03-31: 943109 USD Inspect Capital Expenditure Open source
2024 2023-04-01 – 2024-03-31	0	12636568 Derived	-12636568	-428394 Derived	-12208174	-10380677 Derived	Source 2023-04-01 – 2024-03-31: 0 USD Inspect Revenue Open source 2023-04-01 – 2024-03-31: -12636568 USD Inspect Operating Income Open source 2023-04-01 – 2024-03-31: -12208174 USD Inspect Net Income Open source 2023-04-01 – 2024-03-31: -10129810 USD Inspect Operating Cash Flow Open source 2023-04-01 – 2024-03-31: 250867 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-03-31	Revenue	886572	Revenue: 886572 Open source
20172017-03-31	Revenue	392073	Revenue: 392073 Open source
20182018-03-31	Revenue	149625	Revenue: 149625 Open source
20192019-03-31	Revenue	229625	Revenue: 229625 Open source
20202020-03-31	Revenue	650187	Revenue: 650187 Open source
20212021-03-31	Revenue	659104	Revenue: 659104 Open source
20222022-03-31	Revenue	294165	Revenue: 294165 Open source
20232023-03-31	Revenue	574245	Revenue: 574245 Open source
20242024-03-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-03-31	Year over year	No prior comparable period	Revenue: 886572 Open source
20172017-03-31	Year over year	-55.8%	Revenue: 392073 Open source Revenue: 886572 Open source
20182018-03-31	Year over year	-61.8%	Revenue: 149625 Open source Revenue: 392073 Open source
20192019-03-31	Year over year	53.5%	Revenue: 229625 Open source Revenue: 149625 Open source
20202020-03-31	Year over year	183.2%	Revenue: 650187 Open source Revenue: 229625 Open source
20212021-03-31	Year over year	1.4%	Revenue: 659104 Open source Revenue: 650187 Open source
20222022-03-31	Year over year	-55.4%	Revenue: 294165 Open source Revenue: 659104 Open source
20232023-03-31	Year over year	95.2%	Revenue: 574245 Open source Revenue: 294165 Open source
20242024-03-31	Year over year	-100%	Revenue: 0 Open source Revenue: 574245 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,072% 2023

Net margin -2,094.9% 2023

Free cash flow margin -1,993.6% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-03-31	Operating margin	-494.6%	Operating Income: -4384834 Open source Revenue: 886572 Open source
20172017-03-31	Operating margin	-1,555.4%	Operating Income: -6098357 Open source Revenue: 392073 Open source
20182018-03-31	Operating margin	-3,228.8%	Operating Income: -4831116 Open source Revenue: 149625 Open source
20192019-03-31	Operating margin	-2,612.5%	Operating Income: -5999017 Open source Revenue: 229625 Open source
20202020-03-31	Operating margin	-912%	Operating Income: -5929988 Open source Revenue: 650187 Open source
20212021-03-31	Operating margin	-1,197.3%	Operating Income: -7891499 Open source Revenue: 659104 Open source
20222022-03-31	Operating margin	-3,542.5%	Operating Income: -10420885 Open source Revenue: 294165 Open source
20232023-03-31	Operating margin	-2,072%	Operating Income: -11898638 Open source Revenue: 574245 Open source
20242024-03-31	Operating margin	Not reported	Operating Income: -12636568 Open source Revenue: 0 Open source
20162016-03-31	Net margin	-549.6%	Net Income: -4872329 Open source Revenue: 886572 Open source
20172017-03-31	Net margin	-1,855.8%	Net Income: -7276113 Open source Revenue: 392073 Open source
20182018-03-31	Net margin	-3,795.9%	Net Income: -5679558 Open source Revenue: 149625 Open source
20192019-03-31	Net margin	-2,697.8%	Net Income: -6194719 Open source Revenue: 229625 Open source
20202020-03-31	Net margin	-980.3%	Net Income: -6373948 Open source Revenue: 650187 Open source
20212021-03-31	Net margin	-1,196.6%	Net Income: -7886709 Open source Revenue: 659104 Open source
20222022-03-31	Net margin	-3,540.9%	Net Income: -10416091 Open source Revenue: 294165 Open source
20232023-03-31	Net margin	-2,094.9%	Net Income: -12029786 Open source Revenue: 574245 Open source
20242024-03-31	Net margin	Not reported	Net Income: -12208174 Open source Revenue: 0 Open source
20162016-03-31	Free cash flow margin	Not reported	Revenue: 886572 Open source
20172017-03-31	Free cash flow margin	-898.4%	Revenue: 392073 Open source Operating Cash Flow: -3505900 Open source Capital Expenditure: 16433 Open source
20182018-03-31	Free cash flow margin	-2,630.2%	Revenue: 149625 Open source Operating Cash Flow: -3910680 Open source Capital Expenditure: 24823 Open source
20192019-03-31	Free cash flow margin	-1,869.8%	Revenue: 229625 Open source Operating Cash Flow: -4293433 Open source Capital Expenditure: 0 Open source
20202020-03-31	Free cash flow margin	-822.7%	Revenue: 650187 Open source Operating Cash Flow: -5197608 Open source Capital Expenditure: 151665 Open source
20212021-03-31	Free cash flow margin	-1,035.5%	Revenue: 659104 Open source Operating Cash Flow: -6764940 Open source Capital Expenditure: 59881 Open source
20222022-03-31	Free cash flow margin	-3,439%	Revenue: 294165 Open source Operating Cash Flow: -9767157 Open source Capital Expenditure: 349193 Open source
20232023-03-31	Free cash flow margin	-1,993.6%	Revenue: 574245 Open source Operating Cash Flow: -10505128 Open source Capital Expenditure: 943109 Open source
20242024-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -10129810 Open source Capital Expenditure: 250867 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10.1M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-03-31	Operating cash flow	Not reported	No source recorded
20172017-03-31	Operating cash flow	-3505900	Operating Cash Flow: -3505900 Open source
20182018-03-31	Operating cash flow	-3910680	Operating Cash Flow: -3910680 Open source
20192019-03-31	Operating cash flow	-4293433	Operating Cash Flow: -4293433 Open source
20202020-03-31	Operating cash flow	-5197608	Operating Cash Flow: -5197608 Open source
20212021-03-31	Operating cash flow	-6764940	Operating Cash Flow: -6764940 Open source
20222022-03-31	Operating cash flow	-9767157	Operating Cash Flow: -9767157 Open source
20232023-03-31	Operating cash flow	-10505128	Operating Cash Flow: -10505128 Open source
20242024-03-31	Operating cash flow	-10129810	Operating Cash Flow: -10129810 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -10.4M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-03-31	Free cash flow	Unavailable	No source recorded
20172017-03-31	Free cash flow	-3522333	Operating Cash Flow: -3505900 Open source Capital Expenditure: 16433 Open source
20182018-03-31	Free cash flow	-3935503	Operating Cash Flow: -3910680 Open source Capital Expenditure: 24823 Open source
20192019-03-31	Free cash flow	-4293433	Operating Cash Flow: -4293433 Open source Capital Expenditure: 0 Open source
20202020-03-31	Free cash flow	-5349273	Operating Cash Flow: -5197608 Open source Capital Expenditure: 151665 Open source
20212021-03-31	Free cash flow	-6824821	Operating Cash Flow: -6764940 Open source Capital Expenditure: 59881 Open source
20222022-03-31	Free cash flow	-10116350	Operating Cash Flow: -9767157 Open source Capital Expenditure: 349193 Open source
20232023-03-31	Free cash flow	-11448237	Operating Cash Flow: -10505128 Open source Capital Expenditure: 943109 Open source
20242024-03-31	Free cash flow	-10380677	Operating Cash Flow: -10129810 Open source Capital Expenditure: 250867 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

30.1% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-03-31	Liabilities / assets	40.6%	Total Liabilities: 1026750 Open source Total Assets: 2529116 Open source
20172017-03-31	Liabilities / assets	65.5%	Total Liabilities: 1130956 Open source Total Assets: 1726368 Open source
20182018-03-31	Liabilities / assets	17.9%	Total Liabilities: 1319110 Open source Total Assets: 7351904 Open source
20192019-03-31	Liabilities / assets	44.2%	Total Liabilities: 1823886 Open source Total Assets: 4122964 Open source
20202020-03-31	Liabilities / assets	10.7%	Total Liabilities: 1110260 Open source Total Assets: 10387686 Open source
20212021-03-31	Liabilities / assets	12.9%	Total Liabilities: 1375226 Open source Total Assets: 10668916 Open source
20222022-03-31	Liabilities / assets	12.5%	Total Liabilities: 2426554 Open source Total Assets: 19417954 Open source
20232023-03-31	Liabilities / assets	14%	Total Liabilities: 2444730 Open source Total Assets: 17508940 Open source
20242024-03-31	Liabilities / assets	30.1%	Total Liabilities: 2479650 Open source Total Assets: 8245982 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.4× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-03-31	Current assets / current liabilities	4.51×	Current Assets: 2376502 Open source Current Liabilities: 526611 Open source
20172017-03-31	Current assets / current liabilities	2.61×	Current Assets: 1597252 Open source Current Liabilities: 611756 Open source
20182018-03-31	Current assets / current liabilities	15.13×	Current Assets: 7230250 Open source Current Liabilities: 477957 Open source
20192019-03-31	Current assets / current liabilities	2.21×	Current Assets: 4038116 Open source Current Liabilities: 1823886 Open source
20202020-03-31	Current assets / current liabilities	9.4×	Current Assets: 10041113 Open source Current Liabilities: 1067720 Open source
20212021-03-31	Current assets / current liabilities	7.53×	Current Assets: 10351738 Open source Current Liabilities: 1375226 Open source
20222022-03-31	Current assets / current liabilities	9.95×	Current Assets: 18157007 Open source Current Liabilities: 1824049 Open source
20232023-03-31	Current assets / current liabilities	10.03×	Current Assets: 15090566 Open source Current Liabilities: 1505088 Open source
20242024-03-31	Current assets / current liabilities	3.4×	Current Assets: 6225788 Open source Current Liabilities: 1829899 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-04-01 – 2017-03-31	−USD 7.28 million Exact value Exact value: -7276113 USD 2016-04-01 – 2017-03-31: -7276113 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2017-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -7276113 USD Concept: fundies:NetIncome Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:NetIncome: -7276113 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316818001643/aemd-20180331.xml#83707 Filing: 000168316818001643 The citation records this snapshot. The page link may show a newer release later.	−USD 3.51 million Exact value Exact value: -3505900 USD 2016-04-01 – 2017-03-31: -3505900 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2017-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -3505900 USD Concept: fundies:OperatingCashFlow Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3505900 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316818001643/aemd-20180331.xml#121897 Filing: 000168316818001643 The citation records this snapshot. The page link may show a newer release later.	USD 16,433 Exact value Exact value: 16433 USD 2016-04-01 – 2017-03-31: 16433 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2017-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 16433 USD Concept: fundies:CapitalExpenditure Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16433 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316818001643/aemd-20180331.xml#122267 Filing: 000168316818001643 The citation records this snapshot. The page link may show a newer release later.	−USD 3.52 million Calculation and evidence -3505900 − 16433 USD Exact free cash flow: -3522333 USD 2016-04-01 – 2017-03-31: -3505900 USD · Inspect Operating Cash Flow · Source 2016-04-01 – 2017-03-31: 16433 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2017-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -3522333 USD Concept: free-cash-flow Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3505900 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316818001643/aemd-20180331.xml#121897 Filing: 000168316818001643 Input fundies:CapitalExpenditure: 16433 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316818001643/aemd-20180331.xml#122267 Filing: 000168316818001643 The citation records this snapshot. The page link may show a newer release later.
2018 2017-04-01 – 2018-03-31	−USD 5.68 million Exact value Exact value: -5679558 USD 2017-04-01 – 2018-03-31: -5679558 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2018-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -5679558 USD Concept: fundies:NetIncome Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:NetIncome: -5679558 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316819002070/aemd-20190331.xml#157208 Filing: 000168316819002070 The citation records this snapshot. The page link may show a newer release later.	−USD 3.91 million Exact value Exact value: -3910680 USD 2017-04-01 – 2018-03-31: -3910680 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2018-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -3910680 USD Concept: fundies:OperatingCashFlow Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3910680 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316819002070/aemd-20190331.xml#160864 Filing: 000168316819002070 The citation records this snapshot. The page link may show a newer release later.	USD 24,823 Exact value Exact value: 24823 USD 2017-04-01 – 2018-03-31: 24823 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2018-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 24823 USD Concept: fundies:CapitalExpenditure Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 24823 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316819002070/aemd-20190331.xml#161234 Filing: 000168316819002070 The citation records this snapshot. The page link may show a newer release later.	−USD 3.94 million Calculation and evidence -3910680 − 24823 USD Exact free cash flow: -3935503 USD 2017-04-01 – 2018-03-31: -3910680 USD · Inspect Operating Cash Flow · Source 2017-04-01 – 2018-03-31: 24823 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2018-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -3935503 USD Concept: free-cash-flow Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3910680 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316819002070/aemd-20190331.xml#160864 Filing: 000168316819002070 Input fundies:CapitalExpenditure: 24823 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316819002070/aemd-20190331.xml#161234 Filing: 000168316819002070 The citation records this snapshot. The page link may show a newer release later.
2019 2018-04-01 – 2019-03-31	−USD 6.19 million Exact value Exact value: -6194719 USD 2018-04-01 – 2019-03-31: -6194719 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2019-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -6194719 USD Concept: fundies:NetIncome Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:NetIncome: -6194719 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316820002070/aemd-20200331.xml#138024 Filing: 000168316820002070 The citation records this snapshot. The page link may show a newer release later.	−USD 4.29 million Exact value Exact value: -4293433 USD 2018-04-01 – 2019-03-31: -4293433 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2019-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -4293433 USD Concept: fundies:OperatingCashFlow Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4293433 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316820002070/aemd-20200331.xml#150691 Filing: 000168316820002070 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2018-04-01 – 2019-03-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2019-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316820002070/aemd-20200331.xml#150330 Filing: 000168316820002070 The citation records this snapshot. The page link may show a newer release later.	−USD 4.29 million Calculation and evidence -4293433 − 0 USD Exact free cash flow: -4293433 USD 2018-04-01 – 2019-03-31: -4293433 USD · Inspect Operating Cash Flow · Source 2018-04-01 – 2019-03-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2019-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -4293433 USD Concept: free-cash-flow Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4293433 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316820002070/aemd-20200331.xml#150691 Filing: 000168316820002070 Input fundies:CapitalExpenditure: 0 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316820002070/aemd-20200331.xml#150330 Filing: 000168316820002070 The citation records this snapshot. The page link may show a newer release later.
2020 2019-04-01 – 2020-03-31	−USD 6.37 million Exact value Exact value: -6373948 USD 2019-04-01 – 2020-03-31: -6373948 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2020-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -6373948 USD Concept: fundies:NetIncome Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:NetIncome: -6373948 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316821002707/aemd-20210331.xml#123063 Filing: 000168316821002707 The citation records this snapshot. The page link may show a newer release later.	−USD 5.2 million Exact value Exact value: -5197608 USD 2019-04-01 – 2020-03-31: -5197608 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2020-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -5197608 USD Concept: fundies:OperatingCashFlow Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5197608 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316821002707/aemd-20210331.xml#146697 Filing: 000168316821002707 The citation records this snapshot. The page link may show a newer release later.	USD 151,665 Exact value Exact value: 151665 USD 2019-04-01 – 2020-03-31: 151665 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2020-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 151665 USD Concept: fundies:CapitalExpenditure Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 151665 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316821002707/aemd-20210331.xml#147067 Filing: 000168316821002707 The citation records this snapshot. The page link may show a newer release later.	−USD 5.35 million Calculation and evidence -5197608 − 151665 USD Exact free cash flow: -5349273 USD 2019-04-01 – 2020-03-31: -5197608 USD · Inspect Operating Cash Flow · Source 2019-04-01 – 2020-03-31: 151665 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2020-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -5349273 USD Concept: free-cash-flow Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5197608 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316821002707/aemd-20210331.xml#146697 Filing: 000168316821002707 Input fundies:CapitalExpenditure: 151665 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316821002707/aemd-20210331.xml#147067 Filing: 000168316821002707 The citation records this snapshot. The page link may show a newer release later.
2021 2020-04-01 – 2021-03-31	−USD 7.89 million Exact value Exact value: -7886709 USD 2020-04-01 – 2021-03-31: -7886709 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2021-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -7886709 USD Concept: fundies:NetIncome Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:NetIncome: -7886709 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316822004641/aethlon_i10k-033122.htm#840109 Filing: 000168316822004641 The citation records this snapshot. The page link may show a newer release later.	−USD 6.76 million Exact value Exact value: -6764940 USD 2020-04-01 – 2021-03-31: -6764940 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2021-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -6764940 USD Concept: fundies:OperatingCashFlow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6764940 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316822004641/aethlon_i10k-033122.htm#942899 Filing: 000168316822004641 The citation records this snapshot. The page link may show a newer release later.	USD 59,881 Exact value Exact value: 59881 USD 2020-04-01 – 2021-03-31: 59881 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2021-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 59881 USD Concept: fundies:CapitalExpenditure Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59881 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316822004641/aethlon_i10k-033122.htm#944966 Filing: 000168316822004641 The citation records this snapshot. The page link may show a newer release later.	−USD 6.82 million Calculation and evidence -6764940 − 59881 USD Exact free cash flow: -6824821 USD 2020-04-01 – 2021-03-31: -6764940 USD · Inspect Operating Cash Flow · Source 2020-04-01 – 2021-03-31: 59881 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2021-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -6824821 USD Concept: free-cash-flow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6764940 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316822004641/aethlon_i10k-033122.htm#942899 Filing: 000168316822004641 Input fundies:CapitalExpenditure: 59881 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316822004641/aethlon_i10k-033122.htm#944966 Filing: 000168316822004641 The citation records this snapshot. The page link may show a newer release later.
2022 2021-04-01 – 2022-03-31	−USD 10.42 million Exact value Exact value: -10416091 USD 2021-04-01 – 2022-03-31: -10416091 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2022-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -10416091 USD Concept: fundies:NetIncome Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:NetIncome: -10416091 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316823004487/aethlon_i10k-33123.htm#794499 Filing: 000168316823004487 The citation records this snapshot. The page link may show a newer release later.	−USD 9.77 million Exact value Exact value: -9767157 USD 2021-04-01 – 2022-03-31: -9767157 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2022-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -9767157 USD Concept: fundies:OperatingCashFlow Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9767157 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316823004487/aethlon_i10k-33123.htm#923733 Filing: 000168316823004487 The citation records this snapshot. The page link may show a newer release later.	USD 349,193 Exact value Exact value: 349193 USD 2021-04-01 – 2022-03-31: 349193 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2022-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 349193 USD Concept: fundies:CapitalExpenditure Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 349193 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316823004487/aethlon_i10k-33123.htm#925793 Filing: 000168316823004487 The citation records this snapshot. The page link may show a newer release later.	−USD 10.12 million Calculation and evidence -9767157 − 349193 USD Exact free cash flow: -10116350 USD 2021-04-01 – 2022-03-31: -9767157 USD · Inspect Operating Cash Flow · Source 2021-04-01 – 2022-03-31: 349193 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2022-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -10116350 USD Concept: free-cash-flow Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9767157 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316823004487/aethlon_i10k-33123.htm#923733 Filing: 000168316823004487 Input fundies:CapitalExpenditure: 349193 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316823004487/aethlon_i10k-33123.htm#925793 Filing: 000168316823004487 The citation records this snapshot. The page link may show a newer release later.
2023 2022-04-01 – 2023-03-31	−USD 12.03 million Exact value Exact value: -12029786 USD 2022-04-01 – 2023-03-31: -12029786 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2023-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -12029786 USD Concept: fundies:NetIncome Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:NetIncome: -12029786 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316824004530/aethlon_i10k-033124.htm#918829 Filing: 000168316824004530 The citation records this snapshot. The page link may show a newer release later.	−USD 10.51 million Exact value Exact value: -10505128 USD 2022-04-01 – 2023-03-31: -10505128 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2023-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -10505128 USD Concept: fundies:OperatingCashFlow Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10505128 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316824004530/aethlon_i10k-033124.htm#931078 Filing: 000168316824004530 The citation records this snapshot. The page link may show a newer release later.	USD 943,109 Exact value Exact value: 943109 USD 2022-04-01 – 2023-03-31: 943109 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2023-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 943109 USD Concept: fundies:CapitalExpenditure Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 943109 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316824004530/aethlon_i10k-033124.htm#933178 Filing: 000168316824004530 The citation records this snapshot. The page link may show a newer release later.	−USD 11.45 million Calculation and evidence -10505128 − 943109 USD Exact free cash flow: -11448237 USD 2022-04-01 – 2023-03-31: -10505128 USD · Inspect Operating Cash Flow · Source 2022-04-01 – 2023-03-31: 943109 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2023-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -11448237 USD Concept: free-cash-flow Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10505128 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316824004530/aethlon_i10k-033124.htm#931078 Filing: 000168316824004530 Input fundies:CapitalExpenditure: 943109 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316824004530/aethlon_i10k-033124.htm#933178 Filing: 000168316824004530 The citation records this snapshot. The page link may show a newer release later.
2024 2023-04-01 – 2024-03-31	−USD 12.21 million Exact value Exact value: -12208174 USD 2023-04-01 – 2024-03-31: -12208174 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2024-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -12208174 USD Concept: fundies:NetIncome Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:NetIncome: -12208174 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316825004780/aethlon_i10k-033125.htm#1117955 Filing: 000168316825004780 The citation records this snapshot. The page link may show a newer release later.	−USD 10.13 million Exact value Exact value: -10129810 USD 2023-04-01 – 2024-03-31: -10129810 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2024-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -10129810 USD Concept: fundies:OperatingCashFlow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10129810 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316825004780/aethlon_i10k-033125.htm#1128305 Filing: 000168316825004780 The citation records this snapshot. The page link may show a newer release later.	USD 250,867 Exact value Exact value: 250867 USD 2023-04-01 – 2024-03-31: 250867 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2024-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 250867 USD Concept: fundies:CapitalExpenditure Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 250867 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316825004780/aethlon_i10k-033125.htm#1130413 Filing: 000168316825004780 The citation records this snapshot. The page link may show a newer release later.	−USD 10.38 million Calculation and evidence -10129810 − 250867 USD Exact free cash flow: -10380677 USD 2023-04-01 – 2024-03-31: -10129810 USD · Inspect Operating Cash Flow · Source 2023-04-01 – 2024-03-31: 250867 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2024-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -10380677 USD Concept: free-cash-flow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10129810 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316825004780/aethlon_i10k-033125.htm#1128305 Filing: 000168316825004780 Input fundies:CapitalExpenditure: 250867 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316825004780/aethlon_i10k-033125.htm#1130413 Filing: 000168316825004780 The citation records this snapshot. The page link may show a newer release later.
2025 2024-04-01 – 2025-03-31	−USD 13.39 million Exact value Exact value: -13388089 USD 2024-04-01 – 2025-03-31: -13388089 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2025-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -13388089 USD Concept: fundies:NetIncome Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=USD&dimensions= Input fundies:NetIncome: -13388089 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1025376 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.	−USD 7.65 million Exact value Exact value: -7645532 USD 2024-04-01 – 2025-03-31: -7645532 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2025-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -7645532 USD Concept: fundies:OperatingCashFlow Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7645532 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1034434 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: -0 USD 2024-04-01 – 2025-03-31: -0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2025-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: -0 USD Concept: fundies:CapitalExpenditure Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: -0 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1036531 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.	−USD 7.65 million Calculation and evidence -7645532 − -0 USD Exact free cash flow: -7645532 USD 2024-04-01 – 2025-03-31: -7645532 USD · Inspect Operating Cash Flow · Source 2024-04-01 – 2025-03-31: -0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2025-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -7645532 USD Concept: free-cash-flow Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7645532 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1034434 Filing: 000168316826004710 Input fundies:CapitalExpenditure: -0 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1036531 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.
2026 2025-04-01 – 2026-03-31	−USD 7.15 million Exact value Exact value: -7151469 USD 2025-04-01 – 2026-03-31: -7151469 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aethlon Medical, Inc. · 2026-03-31 Aethlon Medical, Inc. (edgar:882291) Net Income: -7151469 USD Concept: fundies:NetIncome Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ANetIncome&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=USD&dimensions= Input fundies:NetIncome: -7151469 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1025008 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.	−USD 7 million Exact value Exact value: -6998392 USD 2025-04-01 – 2026-03-31: -6998392 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aethlon Medical, Inc. · 2026-03-31 Aethlon Medical, Inc. (edgar:882291) Operating Cash Flow: -6998392 USD Concept: fundies:OperatingCashFlow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3AOperatingCashFlow&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6998392 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1033971 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.	USD 3,704 Exact value Exact value: 3704 USD 2025-04-01 – 2026-03-31: 3704 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aethlon Medical, Inc. · 2026-03-31 Aethlon Medical, Inc. (edgar:882291) Capital Expenditure: 3704 USD Concept: fundies:CapitalExpenditure Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291/explain?concept=fundies%3ACapitalExpenditure&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3704 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1036082 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.	−USD 7 million Calculation and evidence -6998392 − 3704 USD Exact free cash flow: -7002096 USD 2025-04-01 – 2026-03-31: -6998392 USD · Inspect Operating Cash Flow · Source 2025-04-01 – 2026-03-31: 3704 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aethlon Medical, Inc. · 2026-03-31 Aethlon Medical, Inc. (edgar:882291) Free cash flow: -7002096 USD Concept: free-cash-flow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:14:05Z Snapshot: b55c5f88d49455f46577b49d450f4eb3f21321c84b09f73cec29d59834fb4c83 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882291?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6998392 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1033971 Filing: 000168316826004710 Input fundies:CapitalExpenditure: 3704 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882291/000168316826004710/aethlon_i10k-033126.htm#1036082 Filing: 000168316826004710 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

147 filings · 3,642 latest values · 3,651 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000882291, 882291, AEMD, edgar:882291

Also known as AETHLON MEDICAL, INC., AETHLON MEDICAL INC, AETHLON MEDICAL, INC., Aethlon Medical Inc, Aethlon Medical Inc., Aethlon Medical, Inc., BISHOP EQUITIES INC

Aethlon Medical, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2023-04-01 – 2024-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation